03/31/2025
4:09 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form NT 10-K | |
03/11/2025
8:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
12:45 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 424B3 | |
03/04/2025
5:34 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/28/2025
4:46 PM | NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
PATHSTONE FAMILY OFFICE, LLC (Filed by)
| Form SCHEDULE 13G | |
02/25/2025
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
9:34 AM | METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
7:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form DEF 14A | |
01/08/2025
4:29 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:54 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NKGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. |
12/26/2024
6:20 PM | Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:01 PM | Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:23 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:55 PM | Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Scott Kathleen D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:10 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
4:22 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:01 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
5:06 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
5:05 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
4:25 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:00 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:09 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
4:16 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2024
4:26 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
7:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
5:45 PM | CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/22/2024
4:22 PM | CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
| Form SC 13G | |
08/22/2024
3:42 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
7:31 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form ARS | |
07/22/2024
4:19 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form DEF 14A | |
07/18/2024
4:52 PM | Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
4:53 PM | Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:25 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
They Won’t Tell You This About Gold (Ad) Inflation, digital currency, and government policy are quietly eating away at your savings — and most people won't realize it until it's too late.
A new underground report, Gold’s Next Move, reveals why gold could be on the edge of a major breakout — and what you should be doing right now to protect your wealth before the next big move hits. This underground gold report could be the most important guide you read before the next market shock |
07/17/2024
7:15 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:58 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form PRER14A | |
07/12/2024
6:19 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
4:21 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 424B3 | |
07/08/2024
11:15 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form EFFECT | |
06/27/2024
3:34 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form S-1/A | |
06/21/2024
3:14 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:54 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form S-1/A | |
05/13/2024
7:05 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
1:42 PM | METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
| Form SC 13G/A | |
04/29/2024
4:20 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
| Form 10-K/A | |
